Publication | Closed Access

The magnitude of HIV-1 resistance to the CCR5 antagonist maraviroc may impart a differential alteration in HIV-1 tropism for macrophages and T-cell subsets

InflammationCcr5 Antagonist MaravirocHiv-1 ResistanceHuman RetrovirusImmunologyAntiviral ResponseChronic Viral InfectionHivMedicineCell BiologyHiv-1 Tropism